Ketamine is the first exemplar of a rapid-acting antidepressant with efficacy for treatment-
resistant symptoms of mood disorders. Its discovery emerged from a reconceptualization of
the biology of depression. Neurobiological insights into ketamine efficacy shed new light on
the mechanisms underlying antidepressant efficacy.